Elevation Wealth Partners’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Elevation Wealth Partners’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25	Closed	-$59	–	533
2024 Q3	$59	Buy	+25	New	+$50	﹤0.01%	460

Elevation Wealth Partners's AUGX Position: Q4 2024 in Review

Elevation Wealth Partners sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 25 shares — an estimated $59 sold.

Elevation Wealth Partners first reported a position in AUGX in Q3 2024 and held it in 1 quarter. The position peaked at $59 in Q3 2024. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

Elevation Wealth Partners reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Elevation Wealth Partners sold 25 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $59.
Elevation Wealth Partners first reported a position in Augmedix, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Elevation Wealth Partners's Augmedix, Inc. Common Stock position peaked at $59 in Q3 2024.
0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Elevation Wealth Partners's 13F filing for Q4 2024, filed 29 Jan 2025.